Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2012
12/11/2012US8329070 Liposomal apparatus and manufacturing method
12/11/2012US8328787 Pain management methods and apparatus
12/11/2012CA2735526C Compositions comprising solid particles encapsulated in a cross-linked silicone matrix, and methods of making the same
12/11/2012CA2650202C Esters of l-carnitine or alkanoyl l-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds
12/11/2012CA2639048C Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis
12/11/2012CA2620374C Pharmaceutical compositions for the treatment of inner ear disorders
12/11/2012CA2611901C Spray-drying process for producing a dry carnitine powder or granulate
12/11/2012CA2560010C Antimicrobial compositions
12/11/2012CA2552679C Tulobuterol adhesive patch
12/11/2012CA2552569C Direct compression formulation and process
12/11/2012CA2548864C Percutaneous absorption-type pharmaceutical preparation
12/11/2012CA2540848C Method for stabilizing antibody and stabilized solution-type antibody preparation
12/11/2012CA2507524C Administration form for pharmaceutically active peptides with sustained release and method for the production thereof
12/11/2012CA2484632C Processes for forming a drug delivery device
12/11/2012CA2477516C Pharmaceutical formulation comprising melatonin
12/11/2012CA2420061C Pharmaceutical composition for depot administration of rotigotine
12/11/2012CA2328996C Implants for administering substances and methods of producing implants
12/10/2012DE202012011128U1 Bonbon oder Kaugummi zur Lippenpflege und/oder -regeneration Candy or chewing gum for lip care and / or regeneration
12/06/2012WO2012167212A2 Liposomal mitigation of drug-induced long qt syndrome and potassium delayed-rectifier current
12/06/2012WO2012167018A1 Targeted delivery of retinoid compounds to the sebaceous glands
12/06/2012WO2012166923A2 Drug loaded polymeric nanoparticles and methods of making and using same
12/06/2012WO2012166884A2 Encapsulated polar materials and methods of preparation
12/06/2012WO2012166796A1 Magnetic immunostimulatory systems and methods related thereto
12/06/2012WO2012166539A1 Compositions for preventing cardiac arrhythmia
12/06/2012WO2012166474A1 Controlled release solid dose forms
12/06/2012WO2012166070A1 Dry powder formulation with improved flow characteristics
12/06/2012WO2012165995A1 Photodynamic treatment method for malignant tumors
12/06/2012WO2012165917A1 Stable liquid formulation of etanercept
12/06/2012WO2012165815A2 Nano-vehicle derived from tumor tissue, and cancer vaccine using same
12/06/2012WO2012165621A1 TABLET CONTAINING LIMAPROST AND β-CYCLODEXTRIN
12/06/2012WO2012165468A1 Method for manufacturing liquid crystalline composition containing lipophilic compound in high concentration, and liquid crystalline composition manufactured by said method
12/06/2012WO2012165254A1 Ropinirole-containing adhesive skin patch and packaged product thereof
12/06/2012WO2012165253A1 Ropinirole-containing adhesive patch and packaging therefor
12/06/2012WO2012164494A1 Composition for controlled release of buprenorphine
12/06/2012WO2012163937A2 Solid solutions of polyphenols
12/06/2012WO2012163893A1 Composition and tablet comprising raltegravir
12/06/2012WO2012163827A2 Ophthalmic preparation comprising a pgf2alpha analogue
12/06/2012WO2012163704A2 Inhalator and capsule for an inhalator
12/06/2012WO2012163665A1 Transdermal therapeutic system comprising buprenorphine and an alpha-hydroxy acid
12/06/2012WO2012163501A1 Nasal pharmaceutical formulation
12/06/2012WO2012163267A1 Compound chemical medicine acting on respiratory disease, preparation process and use thereof
12/06/2012WO2012162945A1 Mangiferin aglycone crystal form i and preparation method thereof
12/06/2012WO2012162840A1 Polysaccharide-based hydrogel polymer and uses thereof
12/06/2012WO2012162828A1 Matriptase inhibitors and uses thereof against orthomyxoviridae infections
12/06/2012WO2012162820A1 Maleimide-functionalized gold nanoparticles
12/06/2012WO2012162807A1 Brain tumor targeting peptides and methods
12/06/2012WO2012162789A1 Polymers for reversing heparin-based anticoagulation
12/06/2012WO2012162778A1 Oral pharmaceutical composition and use thereof
12/06/2012WO2012162777A1 Oral pharmaceutical composition comprising a proton pump inhibitor and a prokinetic agent that can be used in excess stomach acid disorders
12/06/2012WO2012142292A3 Biofunctionalized polymer microparticles for biotherapeutic delivery and processes for using and making the same
12/06/2012WO2012142159A3 Structural mutations in titin cause dilated cardiomyopathy
12/06/2012WO2012142067A3 Formulations, salts, and solid forms of substituted cyclohexylmethanamines, processes for preparation, and uses thereof
12/06/2012WO2012139246A3 Sunscreening emulsion containing two specific amphiphilic copolymers and at least a lipophilic organic uv filter
12/06/2012WO2012129024A3 Compositions for encapsulating biomaterials and uses related thereto
12/06/2012WO2012119070A3 Silicone-based ophthalmic formulations
12/06/2012WO2012106281A3 Multimodal trail molecules and uses in cellular therapies
12/06/2012WO2012091523A3 Carrier for negatively charged drugs comprising a cationic lipid and a preparation method thereof
12/06/2012WO2012079092A3 Testosterone undecanoate compositions
12/06/2012WO2012049676A3 Apparatuses and methods of intravaginal support and/or distension
12/06/2012WO2011144335A8 Stable ready to use injectable paracetamol formulation
12/06/2012WO2011127244A8 ATAZANAVIR SULFATE FORMULATIONS WITH IMPROVED pH EFFECT
12/06/2012US20120310187 Transparent transdermal nicotine delivery devices
12/06/2012US20120310144 Vision through photodynamic therapy of the eye
12/06/2012US20120309837 Bronchodilating Beta-Agonist Compositions and Methods
12/06/2012US20120309836 Methods and compositions for administration of trpv1 agonists
12/06/2012US20120309823 Percutaneous absorption preparations
12/06/2012US20120309815 Compositions and methods for topical delivery of oligonucleotides
12/06/2012US20120309809 Process and product
12/06/2012US20120309628 Bioactive agent delivery particles
12/06/2012US20120308825 Nano-fibrous microspheres and methods for making the same
12/06/2012US20120308671 Nasal ointment based on white petroleum jelly
12/06/2012US20120308663 Lipid nanocapsules, method for preparing same and use thereof as a drug
12/06/2012US20120308662 Particulate preparation and method for producing the same
12/06/2012US20120308661 Orally administrable pharmaceutical pellet of epidermal growth factor
12/06/2012US20120308660 Nanocoatings for biological materials
12/06/2012US20120308659 Pellet formulation for the treatment of the intenstinal tract
12/06/2012US20120308658 Methods and compositions to treat hemorrhagic conditions of the brain
12/06/2012US20120308657 Magnetic nanostructures as theranostic agents
12/06/2012US20120308656 Sugar-coated preparation and production method for the same
12/06/2012US20120308655 Delivery Carrier
12/06/2012US20120308654 Abuse-proofed dosage form
12/06/2012US20120308653 Wormwood pill containing 95% of wormwood ethyl alcohol extract that has inactivation efficacy of the h1n1 virus and the h9n2 avian influenza virus
12/06/2012US20120308652 Oral form of administration comprising entecavir
12/06/2012US20120308651 Salts of benzimidazolyl pyridyl ethers and formulations thereof
12/06/2012US20120308650 Modified alginates for cell encapsulation and cell therapy
12/06/2012US20120308649 Bacterial cellulose composite with capsules embedded therein and preparation thereof
12/06/2012US20120308648 Methods of treating hot flashes with formulations for transdermal or transmucosal application
12/06/2012US20120308647 Use of mir-30e to treat vascular lesions
12/06/2012US20120308646 Tetracyclic anthraquinones possessing anti-cancer properties
12/06/2012US20120308645 Compositions and methods for sirna inhibition of hif-1 alpha
12/06/2012US20120308644 Compositions for mucosal delivery of agents
12/06/2012US20120308643 Liposomal mitigation of drug-induced long qt syndrome and potassium delayed-rectifier current
12/06/2012US20120308642 Inhibiting hepatitis c viral replication with sirna combinations
12/06/2012US20120308641 Compositions and Methods for Enhancing Coagulation Factor VIII Function
12/06/2012US20120308640 Amphiphilic janus-dendrimers
12/06/2012US20120308639 Mesocellular Oxide Foams as Hemostatic Compositions and Methods of Use
12/06/2012US20120308638 Antimicrobial peptides
12/06/2012US20120308637 Compositions comprising extracts of boswellia, tea tree, aloe and lavender oil and methods of treating wounds, burns and skin injuries therewith
12/06/2012US20120308635 Melt extruded thin strips containing coated pharmaceutical
12/06/2012US20120308634 Gum delivery system
1 ... 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 ... 2991